Position in OGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,486,692
+$973,565 QoQ
Shares Held
109,800
+28.2% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#128
of 626 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Integrated Wealth Concepts LLC holds $214,639,248 across 18 Drug Manufacturers - General names. OGN ranks #14 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
60,927 | $73,077,677 | |
| 2 | JNJ |
Johnson & Johnson
|
162,906 | $41,373,236 | |
| 3 | MRK |
Merck & Co., Inc.
|
162,596 | $20,893,586 | |
| 4 | ABBV |
AbbVie Inc.
|
78,969 | $19,871,759 | |
| 5 | PFE |
Pfizer Inc
|
613,403 | $14,770,744 | |
| 6 | AMGN |
Amgen Inc
|
35,828 | $12,974,035 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
222,207 | $12,803,567 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
40,048 | $5,059,664 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,486,692 | 109,800 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $513,127 | 85,664 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $562,450 | 78,445 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $626,360 | 58,648 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $552,282 | 57,054 | Shares | Other | 2025-08-14 | |
| 2024-12-31 | $349,351 | 23,415 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $538,356 | 28,142 | Shares | Other | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||